---
title: "300363.SZ (300363.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300363.SZ/news.md"
symbol: "300363.SZ"
name: "300363.SZ"
parent: "https://longbridge.com/en/quote/300363.SZ.md"
datetime: "2026-05-21T01:54:31.917Z"
locales:
  - [en](https://longbridge.com/en/quote/300363.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300363.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300363.SZ/news.md)
---

# 300363.SZ (300363.SZ) — Related News

### [Claiming 430 million yuan! Porton's "wishful thinking" has angered Novartis](https://longbridge.com/en/news/286914083.md)
*2026-05-19T12:33:10.000Z*
> Porton is embroiled in a legal dispute due to Novartis's request to terminate the agreement and claim €54.7 million (app

### [Porton: Released a clarification announcement regarding the compensation claim from NOVARTIS AG](https://longbridge.com/en/news/286890135.md)
*2026-05-19T09:58:18.000Z*
> Porton issued a clarification announcement in response to the NOVARTIS AG compensation matter. The company stated that N

### [Porton clarified: Novartis and its subsidiaries contributed approximately 0.1% of the company's total revenue, having a minimal impact on the overall business](https://longbridge.com/en/news/286891193.md)
*2026-05-19T09:58:04.000Z*
> Porton announced that the company will disclose the "Announcement on the Progress of External Investment and Major Risk 

### [Mindset Observation Institute: A 90-day eviction notice and a 430 million compensation claim reveal the risks of Chinese pharmaceutical companies going overseas](https://longbridge.com/en/news/286833006.md)
*2026-05-19T00:31:06.000Z*
> Porton’s wholly-owned subsidiary PSI's collaboration with Novartis at its R&D and production base in Slovenia has been u

### [The 90-day eviction order and the 430 million compensation reveal the risks of Chinese pharmaceutical companies going abroad](https://longbridge.com/en/news/286703532.md)
*2026-05-18T02:26:22.000Z*
> Porton announced that its wholly-owned subsidiary PSI's cooperation with Novartis at its research and production base in

### [A-share pharmaceutical company suddenly faces a 430 million yuan lawsuit from an international giant, hitting the 20 cm limit down, exposing the hidden pain of CXO going overseas](https://longbridge.com/en/news/286642202.md)
*2026-05-16T10:03:13.000Z*
> A-share pharmaceutical company Porton is facing a claim of 430 million yuan due to a cooperation dispute with internatio

### [Porton’s Slovenia base is deeply embroiled in "compliance disputes," with substantial losses from its subsidiary dragging down performance](https://longbridge.com/en/news/286425589.md)
*2026-05-14T09:27:23.000Z*
> Porton is facing a legal crisis due to compliance disputes and hefty claims at its R&D and production base in Slovenia. 

### [Dream of going abroad shattered? Porton faces compliance crisis at European base, stock price hits 20CM limit down](https://longbridge.com/en/news/286366022.md)
*2026-05-14T03:34:16.000Z*
> Porton shares gapped down and hit the limit down due to compliance issues faced by its wholly-owned subsidiary PSI at it

### [Novartis suddenly turns against, Porton's European subsidiary faces huge compensation claims](https://longbridge.com/en/news/286281630.md)
*2026-05-13T14:37:13.000Z*
> Porton’s wholly-owned subsidiary PSI is facing a dispute with Novartis in the construction of its R&D production base in